To determine whether DRD1 modulation does affect the tumor immune microenvironment via PD‐L1, a key next step is to use both wild type and DRD1 knockout immunocompetent animals to evaluate the effects of DRD1‐induced PD‐L1 modulation on tumor‐associated immune cells. This evidence concerns the gene CD274 and neoplasm.